News

COVID FAQ – Preventative medication and antiviral treatments

20 September 2022

MS Plus has put together a brief Q&A to help you navigate the latest information and advice on COVID preventative medication and antivirals.

MS Plus Executive Manager Client Engagement and Wellbeing Jodi Haartsen is once again joined by Neurologist and Associate Professor Anneke Van Der Walt and Clinical Nurse Consultant Louise Rath from The Alfred.

Please note: this video discusses a preventative medication and antiviral treatments for COVID. However, you may not require treatment – please seek advice from your healthcare team.

 

 

Related News

MS News

From our CEO: MS medication ‘rapid review’: Make your voice heard!

27 August 2026

Ahead of an upcoming PBAC stakeholder meeting on MS medicines, CEO Rohan Greenland outlines MS Australia’s key messages, including the importance of treatment choice and continued PBS access.

MS News

Have Your Say: PBAC review of MS treatments open for public consultation

27 August 2026

A public consultation is now open as part of a rapid review of PBS-listed medicines for relapsing-remitting MS. The MS community has an important opportunity to share their experiences and help ensure the lived experience of Australians with MS remains central to future PBS decisions.

MS News

Highlights from the 2026 MS Nurses Australasia Conference

27 August 2026

MS Nurses Australasia and their invited presenters shared specialist expertise and insights on MS care at their 27th Annual Conference in August 2026 in Sydney.

Read More
research grants announcementSimon's story

Newsletter subscription

  • This field is for validation purposes and should be left unchanged.

COVID FAQ – Preventative medication and antiviral treatments